Teslas Trading Volume Soars Amid 5.62% Gain, Leading Market Momentum
Generated by AI AgentAinvest Market Brief
Monday, Nov 18, 2024 5:31 pm ET2min read
TSLA--
1. Tesla (Nasdaq: TSLA)
Tesla gained solidly by 5.62%, with the trading volume of 42.75B. Tesla reaffirmed its outperformance rating by Wedbush, with a target price of $400. The company reported Q3 revenue of $71.983 billion, with a net income of $4.821 billion. Tesla dismissed the rumors of FSD licensing discussions with SAIC.
2. Nvidia (Nasdaq: NVDA)
Nvidia dipped mildly by -1.29%, with the trading volume of 30.78B. NVIDIA is maintaining a "buy" rating with a target price of $200 by Rosenblatt. The company's Blackwell processors face overheating issues, impacting delivery schedules. Bank of America notes NVIDIA's upcoming earnings could significantly influence market dynamics.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated surged by 12.96%, with the trading volume of 11.98B. MicroStrategy purchased approximately 51,780 bitcoins for around $4.6 billion in cash.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 1.34%, with the trading volume of 10.16B. Apple faces significant iPhone price hikes due to new tariffs, considers launching a self-branded TV, and lists iPhone XS Max and iPhone 6s Plus as obsolete. Foxconn, an Apple supplier, modified its recruitment ads in India to remove age, gender, and marital status criteria.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 0.18%, with the trading volume of 9.97B. Microsoft has opened its first Japanese R&D center in Tokyo, focusing on integrating robotics with AI. Additionally, Microsoft secured a patent for a tri-fold phone, hinting at future developments in foldable devices, potentially paving the way for the Surface Phone.
6. Palantir Technologies (NYSE: PLTR)
Palantir Technologies plunged by -6.87%, with the trading volume of 8.37B. Palantir witnessed a surge in AI application investments, with a notable increase in trading volume and significant annual growth, highlighting its position as a major player in the AI sector.
7. Coinbase Global (Nasdaq: COIN)
Coinbase Global surged by 6.39%, with the trading volume of 8.01B. Needham maintains a Buy rating on Coinbase Global with a target price of $375. Coinbase Global reported revenue of $42.92 billion for Q3 2024, ending September 30.
8. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 0.06%, with the trading volume of 7.91B. Meta's total trading volume last week reached $380.27 billion with shares closing at $554.08, reflecting significant activity in the market but facing a weekly decline against broader indices.
9. Amazon (Nasdaq: AMZN)
Amazon.Com dipped mildly by -0.45%, with the trading volume of 7.29B. Amazon leverages Pinduoduo's strategies in cross-border e-commerce competition while optimizing supply chain systems using Amazon Web Services.
10. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany dipped mildly by -2.50%, with the trading volume of 6.60B. Eli Lilly's Tirzepatide, the active ingredient in its weight loss drug Zepbound and diabetes treatment Mounjaro, significantly reduces heart failure risk for HFpEF patients with obesity. Eli Lilly also sued the U.S. HRSA over conflicts regarding 340B drug discounts.
Tesla gained solidly by 5.62%, with the trading volume of 42.75B. Tesla reaffirmed its outperformance rating by Wedbush, with a target price of $400. The company reported Q3 revenue of $71.983 billion, with a net income of $4.821 billion. Tesla dismissed the rumors of FSD licensing discussions with SAIC.
2. Nvidia (Nasdaq: NVDA)
Nvidia dipped mildly by -1.29%, with the trading volume of 30.78B. NVIDIA is maintaining a "buy" rating with a target price of $200 by Rosenblatt. The company's Blackwell processors face overheating issues, impacting delivery schedules. Bank of America notes NVIDIA's upcoming earnings could significantly influence market dynamics.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated surged by 12.96%, with the trading volume of 11.98B. MicroStrategy purchased approximately 51,780 bitcoins for around $4.6 billion in cash.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 1.34%, with the trading volume of 10.16B. Apple faces significant iPhone price hikes due to new tariffs, considers launching a self-branded TV, and lists iPhone XS Max and iPhone 6s Plus as obsolete. Foxconn, an Apple supplier, modified its recruitment ads in India to remove age, gender, and marital status criteria.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 0.18%, with the trading volume of 9.97B. Microsoft has opened its first Japanese R&D center in Tokyo, focusing on integrating robotics with AI. Additionally, Microsoft secured a patent for a tri-fold phone, hinting at future developments in foldable devices, potentially paving the way for the Surface Phone.
6. Palantir Technologies (NYSE: PLTR)
Palantir Technologies plunged by -6.87%, with the trading volume of 8.37B. Palantir witnessed a surge in AI application investments, with a notable increase in trading volume and significant annual growth, highlighting its position as a major player in the AI sector.
7. Coinbase Global (Nasdaq: COIN)
Coinbase Global surged by 6.39%, with the trading volume of 8.01B. Needham maintains a Buy rating on Coinbase Global with a target price of $375. Coinbase Global reported revenue of $42.92 billion for Q3 2024, ending September 30.
8. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 0.06%, with the trading volume of 7.91B. Meta's total trading volume last week reached $380.27 billion with shares closing at $554.08, reflecting significant activity in the market but facing a weekly decline against broader indices.
9. Amazon (Nasdaq: AMZN)
Amazon.Com dipped mildly by -0.45%, with the trading volume of 7.29B. Amazon leverages Pinduoduo's strategies in cross-border e-commerce competition while optimizing supply chain systems using Amazon Web Services.
10. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany dipped mildly by -2.50%, with the trading volume of 6.60B. Eli Lilly's Tirzepatide, the active ingredient in its weight loss drug Zepbound and diabetes treatment Mounjaro, significantly reduces heart failure risk for HFpEF patients with obesity. Eli Lilly also sued the U.S. HRSA over conflicts regarding 340B drug discounts.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet